June 6, 2025: Novo Nordisk Asked to Add NAION, Which Can Cause Blindness, to Ozempic Warning Label The European Medicines Agency has concluded that taking Ozempic and other medications that contain semaglutide may increase someones risk of developing NAION
Collagen & melanin-inhibiting blend
The most closely watched data for retatrutide to date come from its Phase 2 clinical trial , published in The New England Journal of Medicine in 2023 (Jastreboff et al.), which demonstrated substantial weight reduction across dose groups
With every purchase, we donate to the Magee-Womens Research Institute, funding research focused on womens health, an area historically overlooked in clinical science
As of February 5, 2024, legal actions regarding Ozempic are still underway, with lawyers continuing to accept new cases